Product Specifications Active Compound: Retatrutide peptide Strength: 30mg per vial Form: Lyophilized powder Reconstitution Required: Yes, according to a validated laboratory protocol Manufacturer, as listed: Novera Compounds Country of Origin, as listed: United States Brand: Novera Intended Use: Laboratory and in vitro research only Package Content: 1 x 30mg vial Weight: 7 grams Dimensions: Width: 20mm | Height: 40mm | Length: 20mm Human-Use Status: Not approved for human use, clinical application, injection, or consumption Researchers should verify the product label, certificate of analysis, batch identity, purity method, storage requirements, safety data sheet, and manufacturer information before use
GHK-Cu 100mg Vial Reconstitution Syringe Math (U-100 Insulin Syringe) Daily Dosing Schedule (6 Weeks) Frequency: Once daily, subcutaneous Duration: 6 weeks (some individuals choose to take a short break after completing a cycle before starting another depending on goals and response)
AOD 9604 and Cancer Cell Research Rounding out this lipolysis peptides expanding research profile, AOD 9604 has also been explored in laboratory contexts involving cancer cell biology
Although more large trials are needed, the existing data underline its role in brightening protocolsespecially when oral or topical routes fall short
The marketing claims have grown faster than the evidence supports
